NCT05103696View on ClinicalTrials.gov

A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

March 30, 2023

Conditions
Elderly PatientsGastrointestinal EndoscopyRemimazolam BesylateEtomidate Combined With Propofol
Interventions
DRUG

Remimazolam Besylate

Remazolam 7mg for the first time (push time 1min), 2.5mg can be added after 2min according to MOAA/S score, no more than 5 times within 15min

DRUG

etomidate combined with propofol

Etomidate 0.1mg/kg+1% propofol 0.5mg/kg for the first time ,etomidate0.05mg/kg+ 1% propofol 0.25 mg/kg can be added according to MOAA/S score

Trial Locations (1)

100049

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT05103696 - A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients | Biotech Hunter | Biotech Hunter